Sugi Predict

Sugi Predict / Compounds / SCHEMBL7782946

SCHEMBL7782946

SCHEMBL7782946

CC(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)Oc1cccc2ccccc12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.50
▸ HSD17B10 Q99714 3/20 0.50
▸ PGR P06401 1/20 0.50
▸ GAA P10253 1/20 0.50
▸ PTGS1 P23219 1/20 0.50
▸ MAPK1 P28482 1/20 0.50
▸ KDM4E B2RXH2 2/20 0.45
▸ HPGD P15428 1/20 0.45
▸ KMT2A Q03164 4/20 0.43
▸ MEN1 O00255 2/20 0.43
▸ RAB9A P51151 1/20 0.43
▸ L3MBTL1 Q9Y468 1/20 0.43
▸ PSMB5 P28074 1/20 0.41
▸ NCEH1 Q6PIU2 1/20 0.40
▸ CARM1 Q86X55 1/20 0.40
▸ PRMT6 Q96LA8 1/20 0.40
▸ ESRRA P11474 1/20 0.40
▸ ALOX5 P09917 2/20 0.40
▸ PTGES O14684 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9811019 1.00 ALDH1A1 (0.50) ALDH1A1HSD17B10PGRGAAPTGS1
SCHEMBL7776373 0.95 ALDH1A1 (0.55) ALDH1A1HSD17B10PGRGAAPTGS1
SCHEMBL7563341 0.80 ALDH1A1 (0.58) ALDH1A1HSD17B10PGRGAAPTGS1
SCHEMBL27660507 0.78 ALDH1A1 (0.58) ALDH1A1HSD17B10PGRGAAPTGS1
SCHEMBL12396105 0.78 ANPEP (0.51) ALDH1A1HSD17B10PGRGAAPTGS1
SCHEMBL7527715 0.78 EPHX2 (0.57) ALDH1A1HSD17B10PGRGAAPTGS1
SCHEMBL4320298 0.78 EPHX2 (0.57) ALDH1A1HSD17B10PGRGAAPTGS1
SCHEMBL10713841 0.77 ALDH1A1 (0.60) ALDH1A1HSD17B10PGRGAAPTGS1
SCHEMBL10714230 0.77 ALDH1A1 (0.60) ALDH1A1HSD17B10PGRGAAPTGS1
SCHEMBL21225960 0.76 CASP1 (0.54) ALDH1A1HSD17B10PGRGAAPTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230225911-A1 ABSORBENT ARTICLE HAVING REAGENTS FOR DETECTING MEDICAL CONDITIONS BABY RX LLC 2023-07-20 — — US disclosed
EP-0713093-B1 Improved methodology for colorimetrically determining the concentration of white blood cells in a biological fluid BAYER AG (US) 2001-10-10 — — EP disclosed
US-5663044-A Methodology for colorimetrically determining the concentration of white blood cells in a biological fluid BAYER CORPORATION (US) 1997-09-02 — — US disclosed
EP-0713093-A2 Improved methodology for colorimetrically determining the concentration of white blood cells in a biological fluid Bayer Corporation (US) 1996-05-22 — — EP disclosed
EP-0157326-B1 COMPOSITION AND TEST DEVICE FOR DETERMINING THE PRESENCE OF LEUKOCYTES, ESTERASE AND PROTEASE IN A TEST SAMPLE MILES INC. (US) 1989-05-31 — — EP disclosed
US-4657855-A DIP-AND-READ, UROGENITAL DISORDERS MILES LABORATORIES, INC. (US) 1987-04-14 — — US disclosed
US-4637979-A Composition and test device for determining the presence of leukocytes containing a zwitterion coupling agent MILES LABORATORIES, INC. (US) 1987-01-20 — — US disclosed
EP-0158204-A2 Composition and test device for determining the presence of leukocytes, containing a zwitterion coupling agent MILES INC. (US) 1985-10-16 — — EP disclosed
EP-0157326-A2 Composition and test device for determining the presence of leukocytes, esterase and protease in a test sample MILES INC. (US) 1985-10-09 — — EP disclosed
US-4499185-A ANALYSIS FOR LEUKOCYTES USING A CHROMOGENIC ESTER AND 3-QUINUCLIDINOL MILES LABORATORIES, INC. (US) 1985-02-12 — — US disclosed